The global Renal Sympathetic Denervation (RDN) Ablation System market size is predicted to grow from US$ 1295 million in 2025 to US$ 10555 million in 2031; it is expected to grow at a CAGR of 41.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A Renal Sympathetic Denervation (RDN) Ablation System is a catheter-based medical device designed to treat resistant hypertension by ablating the sympathetic nerves surrounding the renal arteries. The system delivers energy—typically radiofrequency, ultrasound, or chemical agents—via a dedicated ablation catheter to disrupt renal sympathetic nerve activity, resulting in long-term blood pressure reduction. It typically comprises an ablation catheter, energy generator, control console, and optional temperature or positioning modules. RDN systems are minimally invasive, reproducible, and are being used in both clinical practice and investigational studies globally.
United States market for Renal Sympathetic Denervation (RDN) Ablation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Renal Sympathetic Denervation (RDN) Ablation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Renal Sympathetic Denervation (RDN) Ablation System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Renal Sympathetic Denervation (RDN) Ablation System players cover Medtronic, SoniVie, ReCor Medical（Otsuka）, Abbott, Boston Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The “Renal Sympathetic Denervation (RDN) Ablation System Industry Forecast” looks at past sales and reviews total world Renal Sympathetic Denervation (RDN) Ablation System sales in 2024, providing a comprehensive analysis by region and market sector of projected Renal Sympathetic Denervation (RDN) Ablation System sales for 2025 through 2031. With Renal Sympathetic Denervation (RDN) Ablation System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Renal Sympathetic Denervation (RDN) Ablation System industry.
This Insight Report provides a comprehensive analysis of the global Renal Sympathetic Denervation (RDN) Ablation System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Renal Sympathetic Denervation (RDN) Ablation System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Renal Sympathetic Denervation (RDN) Ablation System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Renal Sympathetic Denervation (RDN) Ablation System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Renal Sympathetic Denervation (RDN) Ablation System.
This report presents a comprehensive overview, market shares, and growth opportunities of Renal Sympathetic Denervation (RDN) Ablation System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Radiofrequency Ablation
Ultrasound Ablation
Other
Segmentation by Application:
Resistant Hypertension
Patients with Essential Hypertension
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
SoniVie
ReCor Medical（Otsuka）
Abbott
Boston Scientific
Ablative Solutions
Shanghai Bio-heart
Symap Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Renal Sympathetic Denervation (RDN) Ablation System market?
What factors are driving Renal Sympathetic Denervation (RDN) Ablation System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Renal Sympathetic Denervation (RDN) Ablation System market opportunities vary by end market size?
How does Renal Sympathetic Denervation (RDN) Ablation System break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Renal Sympathetic Denervation (RDN) Ablation System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Renal Sympathetic Denervation (RDN) Ablation System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Renal Sympathetic Denervation (RDN) Ablation System by Country/Region, 2020, 2024 & 2031
2.2 Renal Sympathetic Denervation (RDN) Ablation System Segment by Type
2.2.1 Radiofrequency Ablation
2.2.2 Ultrasound Ablation
2.2.3 Other
2.3 Renal Sympathetic Denervation (RDN) Ablation System Sales by Type
2.3.1 Global Renal Sympathetic Denervation (RDN) Ablation System Sales Market Share by Type (2020-2025)
2.3.2 Global Renal Sympathetic Denervation (RDN) Ablation System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Renal Sympathetic Denervation (RDN) Ablation System Sale Price by Type (2020-2025)
2.4 Renal Sympathetic Denervation (RDN) Ablation System Segment by Application
2.4.1 Resistant Hypertension
2.4.2 Patients with Essential Hypertension
2.4.3 Other
2.5 Renal Sympathetic Denervation (RDN) Ablation System Sales by Application
2.5.1 Global Renal Sympathetic Denervation (RDN) Ablation System Sale Market Share by Application (2020-2025)
2.5.2 Global Renal Sympathetic Denervation (RDN) Ablation System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Renal Sympathetic Denervation (RDN) Ablation System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Renal Sympathetic Denervation (RDN) Ablation System Breakdown Data by Company
3.1.1 Global Renal Sympathetic Denervation (RDN) Ablation System Annual Sales by Company (2020-2025)
3.1.2 Global Renal Sympathetic Denervation (RDN) Ablation System Sales Market Share by Company (2020-2025)
3.2 Global Renal Sympathetic Denervation (RDN) Ablation System Annual Revenue by Company (2020-2025)
3.2.1 Global Renal Sympathetic Denervation (RDN) Ablation System Revenue by Company (2020-2025)
3.2.2 Global Renal Sympathetic Denervation (RDN) Ablation System Revenue Market Share by Company (2020-2025)
3.3 Global Renal Sympathetic Denervation (RDN) Ablation System Sale Price by Company
3.4 Key Manufacturers Renal Sympathetic Denervation (RDN) Ablation System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Renal Sympathetic Denervation (RDN) Ablation System Product Location Distribution
3.4.2 Players Renal Sympathetic Denervation (RDN) Ablation System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Renal Sympathetic Denervation (RDN) Ablation System by Geographic Region
4.1 World Historic Renal Sympathetic Denervation (RDN) Ablation System Market Size by Geographic Region (2020-2025)
4.1.1 Global Renal Sympathetic Denervation (RDN) Ablation System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Renal Sympathetic Denervation (RDN) Ablation System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Renal Sympathetic Denervation (RDN) Ablation System Market Size by Country/Region (2020-2025)
4.2.1 Global Renal Sympathetic Denervation (RDN) Ablation System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Renal Sympathetic Denervation (RDN) Ablation System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Renal Sympathetic Denervation (RDN) Ablation System Sales Growth
4.4 APAC Renal Sympathetic Denervation (RDN) Ablation System Sales Growth
4.5 Europe Renal Sympathetic Denervation (RDN) Ablation System Sales Growth
4.6 Middle East & Africa Renal Sympathetic Denervation (RDN) Ablation System Sales Growth
5 Americas
5.1 Americas Renal Sympathetic Denervation (RDN) Ablation System Sales by Country
5.1.1 Americas Renal Sympathetic Denervation (RDN) Ablation System Sales by Country (2020-2025)
5.1.2 Americas Renal Sympathetic Denervation (RDN) Ablation System Revenue by Country (2020-2025)
5.2 Americas Renal Sympathetic Denervation (RDN) Ablation System Sales by Type (2020-2025)
5.3 Americas Renal Sympathetic Denervation (RDN) Ablation System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Renal Sympathetic Denervation (RDN) Ablation System Sales by Region
6.1.1 APAC Renal Sympathetic Denervation (RDN) Ablation System Sales by Region (2020-2025)
6.1.2 APAC Renal Sympathetic Denervation (RDN) Ablation System Revenue by Region (2020-2025)
6.2 APAC Renal Sympathetic Denervation (RDN) Ablation System Sales by Type (2020-2025)
6.3 APAC Renal Sympathetic Denervation (RDN) Ablation System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Renal Sympathetic Denervation (RDN) Ablation System by Country
7.1.1 Europe Renal Sympathetic Denervation (RDN) Ablation System Sales by Country (2020-2025)
7.1.2 Europe Renal Sympathetic Denervation (RDN) Ablation System Revenue by Country (2020-2025)
7.2 Europe Renal Sympathetic Denervation (RDN) Ablation System Sales by Type (2020-2025)
7.3 Europe Renal Sympathetic Denervation (RDN) Ablation System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Renal Sympathetic Denervation (RDN) Ablation System by Country
8.1.1 Middle East & Africa Renal Sympathetic Denervation (RDN) Ablation System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Renal Sympathetic Denervation (RDN) Ablation System Revenue by Country (2020-2025)
8.2 Middle East & Africa Renal Sympathetic Denervation (RDN) Ablation System Sales by Type (2020-2025)
8.3 Middle East & Africa Renal Sympathetic Denervation (RDN) Ablation System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Renal Sympathetic Denervation (RDN) Ablation System
10.3 Manufacturing Process Analysis of Renal Sympathetic Denervation (RDN) Ablation System
10.4 Industry Chain Structure of Renal Sympathetic Denervation (RDN) Ablation System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Renal Sympathetic Denervation (RDN) Ablation System Distributors
11.3 Renal Sympathetic Denervation (RDN) Ablation System Customer
12 World Forecast Review for Renal Sympathetic Denervation (RDN) Ablation System by Geographic Region
12.1 Global Renal Sympathetic Denervation (RDN) Ablation System Market Size Forecast by Region
12.1.1 Global Renal Sympathetic Denervation (RDN) Ablation System Forecast by Region (2026-2031)
12.1.2 Global Renal Sympathetic Denervation (RDN) Ablation System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Renal Sympathetic Denervation (RDN) Ablation System Forecast by Type (2026-2031)
12.7 Global Renal Sympathetic Denervation (RDN) Ablation System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Renal Sympathetic Denervation (RDN) Ablation System Product Portfolios and Specifications
13.1.3 Medtronic Renal Sympathetic Denervation (RDN) Ablation System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 SoniVie
13.2.1 SoniVie Company Information
13.2.2 SoniVie Renal Sympathetic Denervation (RDN) Ablation System Product Portfolios and Specifications
13.2.3 SoniVie Renal Sympathetic Denervation (RDN) Ablation System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 SoniVie Main Business Overview
13.2.5 SoniVie Latest Developments
13.3 ReCor Medical（Otsuka）
13.3.1 ReCor Medical（Otsuka） Company Information
13.3.2 ReCor Medical（Otsuka） Renal Sympathetic Denervation (RDN) Ablation System Product Portfolios and Specifications
13.3.3 ReCor Medical（Otsuka） Renal Sympathetic Denervation (RDN) Ablation System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ReCor Medical（Otsuka） Main Business Overview
13.3.5 ReCor Medical（Otsuka） Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Renal Sympathetic Denervation (RDN) Ablation System Product Portfolios and Specifications
13.4.3 Abbott Renal Sympathetic Denervation (RDN) Ablation System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 Boston Scientific
13.5.1 Boston Scientific Company Information
13.5.2 Boston Scientific Renal Sympathetic Denervation (RDN) Ablation System Product Portfolios and Specifications
13.5.3 Boston Scientific Renal Sympathetic Denervation (RDN) Ablation System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Boston Scientific Main Business Overview
13.5.5 Boston Scientific Latest Developments
13.6 Ablative Solutions
13.6.1 Ablative Solutions Company Information
13.6.2 Ablative Solutions Renal Sympathetic Denervation (RDN) Ablation System Product Portfolios and Specifications
13.6.3 Ablative Solutions Renal Sympathetic Denervation (RDN) Ablation System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ablative Solutions Main Business Overview
13.6.5 Ablative Solutions Latest Developments
13.7 Shanghai Bio-heart
13.7.1 Shanghai Bio-heart Company Information
13.7.2 Shanghai Bio-heart Renal Sympathetic Denervation (RDN) Ablation System Product Portfolios and Specifications
13.7.3 Shanghai Bio-heart Renal Sympathetic Denervation (RDN) Ablation System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai Bio-heart Main Business Overview
13.7.5 Shanghai Bio-heart Latest Developments
13.8 Symap Medical
13.8.1 Symap Medical Company Information
13.8.2 Symap Medical Renal Sympathetic Denervation (RDN) Ablation System Product Portfolios and Specifications
13.8.3 Symap Medical Renal Sympathetic Denervation (RDN) Ablation System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Symap Medical Main Business Overview
13.8.5 Symap Medical Latest Developments
14 Research Findings and Conclusion
*If Applicable.
